Oragenics OGEN
NYSE OGEN
$0.34 +0.00 (+0.00%)
As of: Nov 11, 2026 · 9:46 AM EST

Oragenics (OGEN) Cash from Discontinued Operations (2015 - 2016)

Updated

Oragenics (OGEN) reported Cash from Discontinued Operations of -$11,394 for Q4 2016.

Analysis

Oragenics (OGEN) Cash from Discontinued Operations (2015 - 2016) Analysis & Trends

For FY2016, Oragenics posted Cash from Discontinued Operations of -$54,155.

  • By year, Cash from Discontinued Operations came in at $85,105 in FY2015.
  • Five-year quarterly Cash from Discontinued Operations spans a low of -$144,510 in Q3 2016 and a high of $163,719 in Q2 2016.
  • Per Business Quant data, the three quarters before Q4 2016 came in at -$144,510 (Q3 2016), $163,719 (Q2 2016) and -$61,970 (Q1 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 6.56 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Oragenics 1.58 Mn -28.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 -11,394.00
Sep 30, 2016 -144,510.00
Jun 30, 2016 163,719.00
Mar 31, 2016 -61,970.00
Dec 31, 2015 52,349.00
Sep 30, 2015 76,606.00
API Access

Oragenics Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=OGEN&period=max&api_key=YOUR_API_KEY